Clinical Trial Update: Effect of Evolocumab on Vascular Function [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the effect of evolocumab on vascular function in atherosclerotic cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Atherosclerotic Cardiovascular Disease | Phase 4 | Status: COMPLETED